Ligand Pharmaceuticals Incorporated (LGND)
NasdaqGM - NasdaqGM 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 70.37 |
| 開市 | 70.59 |
| 買盤 | 70.53 x 100 |
| 賣出價 | 70.74 x 100 |
| 今日波幅 | 70.43 - 72.08 |
| 52 週波幅 | 49.24 - 94.57 |
| 成交量 | |
| 平均成交量 | 174,588 |
| 市值 | 1.249B |
| Beta 值 (5 年，每月) | 0.92 |
| 市盈率 (最近 12 個月) | 23.29 |
| 每股盈利 (最近 12 個月) | 3.03 |
| 業績公佈日 | 2024年5月07日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 2010年7月02日 |
| 1 年預測目標價 | 116.80 |
ZacksSage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates
Sage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales beat the mark. The newly-launched depression drug Zurzuvae drives the company's top line.
ZacksWall Street Analysts Predict a 45.56% Upside in Ligand (LGND): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 45.6% in Ligand (LGND). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- Zacks
Aptevo (APVO) Stock Plummets 79% in a Week: Here's Why
Aptevo (APVO) plunges after it issues secondary shares, which are not only issued at a significant discount but also substantially dilute the existing shareholder base.
